Logo image of AB9.DE

ABO ENERGY GMBH & CO. KGAA (AB9.DE) Stock Fundamental Analysis

FRA:AB9 - Deutsche Boerse Ag - DE0005760029 - Common Stock - Currency: EUR

43.4  +0.2 (+0.46%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AB9. AB9 was compared to 21 industry peers in the Independent Power and Renewable Electricity Producers industry. AB9 has only an average score on both its financial health and profitability. AB9 is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AB9 had positive earnings in the past year.
In the past year AB9 has reported a negative cash flow from operations.
AB9 had positive earnings in each of the past 5 years.
AB9 had negative operating cash flow in 4 of the past 5 years.
AB9.DE Yearly Net Income VS EBIT VS OCF VS FCFAB9.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

1.2 Ratios

The Return On Assets of AB9 (3.90%) is better than 61.90% of its industry peers.
AB9 has a better Return On Equity (11.31%) than 61.90% of its industry peers.
AB9 has a better Return On Invested Capital (6.94%) than 85.71% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AB9 is above the industry average of 5.06%.
Industry RankSector Rank
ROA 3.9%
ROE 11.31%
ROIC 6.94%
ROA(3y)4.95%
ROA(5y)4.95%
ROE(3y)12.64%
ROE(5y)10.99%
ROIC(3y)8.37%
ROIC(5y)8.5%
AB9.DE Yearly ROA, ROE, ROICAB9.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 5.73%, AB9 is in line with its industry, outperforming 52.38% of the companies in the same industry.
In the last couple of years the Profit Margin of AB9 has declined.
AB9 has a Operating Margin (13.72%) which is in line with its industry peers.
In the last couple of years the Operating Margin of AB9 has declined.
Looking at the Gross Margin, with a value of 47.73%, AB9 is in line with its industry, outperforming 57.14% of the companies in the same industry.
AB9's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.72%
PM (TTM) 5.73%
GM 47.73%
OM growth 3Y-15.15%
OM growth 5Y-7.85%
PM growth 3Y-19.18%
PM growth 5Y-8.69%
GM growth 3Y-17.78%
GM growth 5Y-6.12%
AB9.DE Yearly Profit, Operating, Gross MarginsAB9.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AB9 is still creating some value.
The number of shares outstanding for AB9 remains at a similar level compared to 1 year ago.
AB9 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AB9 has a worse debt to assets ratio.
AB9.DE Yearly Shares OutstandingAB9.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
AB9.DE Yearly Total Debt VS Total AssetsAB9.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

AB9 has an Altman-Z score of 3.02. This indicates that AB9 is financially healthy and has little risk of bankruptcy at the moment.
AB9 has a Altman-Z score of 3.02. This is amongst the best in the industry. AB9 outperforms 80.95% of its industry peers.
AB9 has a Debt/Equity ratio of 1.39. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.39, AB9 is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF N/A
Altman-Z 3.02
ROIC/WACC1.26
WACC5.53%
AB9.DE Yearly LT Debt VS Equity VS FCFAB9.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 10.60 indicates that AB9 has no problem at all paying its short term obligations.
The Current ratio of AB9 (10.60) is better than 100.00% of its industry peers.
A Quick Ratio of 6.73 indicates that AB9 has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 6.73, AB9 belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.6
Quick Ratio 6.73
AB9.DE Yearly Current Assets VS Current LiabilitesAB9.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

7

3. Growth

3.1 Past

AB9 shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.10%.
The Earnings Per Share has been growing by 14.46% on average over the past years. This is quite good.
The Revenue has grown by 48.95% in the past year. This is a very strong growth!
AB9 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.73% yearly.
EPS 1Y (TTM)-6.1%
EPS 3Y22.69%
EPS 5Y14.46%
EPS Q2Q%-22.61%
Revenue 1Y (TTM)48.95%
Revenue growth 3Y52%
Revenue growth 5Y28.73%
Sales Q2Q%91.62%

3.2 Future

The Earnings Per Share is expected to grow by 16.76% on average over the next years. This is quite good.
The Revenue is expected to grow by 10.60% on average over the next years. This is quite good.
EPS Next Y27.76%
EPS Next 2Y26.49%
EPS Next 3Y23.28%
EPS Next 5Y16.76%
Revenue Next Year5.29%
Revenue Next 2Y10.37%
Revenue Next 3Y11.05%
Revenue Next 5Y10.6%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AB9.DE Yearly Revenue VS EstimatesAB9.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
AB9.DE Yearly EPS VS EstimatesAB9.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.67 indicates a correct valuation of AB9.
Compared to the rest of the industry, the Price/Earnings ratio of AB9 is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.46. AB9 is valued slightly cheaper when compared to this.
AB9 is valuated correctly with a Price/Forward Earnings ratio of 12.12.
Based on the Price/Forward Earnings ratio, AB9 is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, AB9 is valued rather cheaply.
Industry RankSector Rank
PE 15.67
Fwd PE 12.12
AB9.DE Price Earnings VS Forward Price EarningsAB9.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AB9 indicates a somewhat cheap valuation: AB9 is cheaper than 71.43% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.61
AB9.DE Per share dataAB9.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

AB9's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AB9's earnings are expected to grow with 23.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.56
PEG (5Y)1.08
EPS Next 2Y26.49%
EPS Next 3Y23.28%

6

5. Dividend

5.1 Amount

AB9 has a Yearly Dividend Yield of 1.50%. Purely for dividend investing, there may be better candidates out there.
AB9's Dividend Yield is a higher than the industry average which is at 3.34.
AB9's Dividend Yield is slightly below the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.5%

5.2 History

The dividend of AB9 is nicely growing with an annual growth rate of 7.99%!
Dividend Growth(5Y)7.99%
Div Incr Years3
Div Non Decr Years3
AB9.DE Yearly Dividends per shareAB9.DE Yearly Dividends per shareYearly Dividends per share 2020 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

21.63% of the earnings are spent on dividend by AB9. This is a low number and sustainable payout ratio.
AB9's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP21.63%
EPS Next 2Y26.49%
EPS Next 3Y23.28%
AB9.DE Yearly Income VS Free CF VS DividendAB9.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M
AB9.DE Dividend Payout.AB9.DE Dividend Payout, showing the Payout Ratio.AB9.DE Dividend Payout.PayoutRetained Earnings

ABO ENERGY GMBH & CO. KGAA

FRA:AB9 (7/21/2025, 7:00:00 PM)

43.4

+0.2 (+0.46%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)03-24 2025-03-24/amc
Earnings (Next)N/A N/A
Inst Owners2.5%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap400.15M
Analysts85.71
Price Target103.7 (138.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.5%
Yearly Dividend0.6
Dividend Growth(5Y)7.99%
DP21.63%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE 15.67
Fwd PE 12.12
P/S 0.9
P/FCF N/A
P/OCF N/A
P/B 1.77
P/tB 1.78
EV/EBITDA 9.61
EPS(TTM)2.77
EY6.38%
EPS(NY)3.58
Fwd EY8.25%
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS48.41
BVpS24.55
TBVpS24.45
PEG (NY)0.56
PEG (5Y)1.08
Profitability
Industry RankSector Rank
ROA 3.9%
ROE 11.31%
ROCE 10.25%
ROIC 6.94%
ROICexc 8.02%
ROICexgc 8.04%
OM 13.72%
PM (TTM) 5.73%
GM 47.73%
FCFM N/A
ROA(3y)4.95%
ROA(5y)4.95%
ROE(3y)12.64%
ROE(5y)10.99%
ROIC(3y)8.37%
ROIC(5y)8.5%
ROICexc(3y)10.05%
ROICexc(5y)10.24%
ROICexgc(3y)10.08%
ROICexgc(5y)10.48%
ROCE(3y)12.36%
ROCE(5y)12.55%
ROICexcg growth 3Y3.15%
ROICexcg growth 5Y-2.54%
ROICexc growth 3Y3.3%
ROICexc growth 5Y-0.83%
OM growth 3Y-15.15%
OM growth 5Y-7.85%
PM growth 3Y-19.18%
PM growth 5Y-8.69%
GM growth 3Y-17.78%
GM growth 5Y-6.12%
F-Score3
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF N/A
Debt/EBITDA 4.81
Cap/Depr 93.06%
Cap/Sales 0.89%
Interest Coverage 5.35
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.6
Quick Ratio 6.73
Altman-Z 3.02
F-Score3
WACC5.53%
ROIC/WACC1.26
Cap/Depr(3y)101.35%
Cap/Depr(5y)118.81%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.1%
EPS 3Y22.69%
EPS 5Y14.46%
EPS Q2Q%-22.61%
EPS Next Y27.76%
EPS Next 2Y26.49%
EPS Next 3Y23.28%
EPS Next 5Y16.76%
Revenue 1Y (TTM)48.95%
Revenue growth 3Y52%
Revenue growth 5Y28.73%
Sales Q2Q%91.62%
Revenue Next Year5.29%
Revenue Next 2Y10.37%
Revenue Next 3Y11.05%
Revenue Next 5Y10.6%
EBIT growth 1Y11.32%
EBIT growth 3Y28.98%
EBIT growth 5Y18.62%
EBIT Next Year65.62%
EBIT Next 3Y30.59%
EBIT Next 5YN/A
FCF growth 1Y89.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.74%
OCF growth 3YN/A
OCF growth 5YN/A